Related references
Note: Only part of the references are listed.Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013
R. Rajendran et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)
Mariana Castanheira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Sarah Santos Goncalves et al.
MYCOSES (2016)
Burden of serious fungal infections in Ukraine
Ali Osmanov et al.
MYCOSES (2015)
Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008-2013: Results from Population-Based Surveillance
Angela Ahlquist Cleveland et al.
PLOS ONE (2015)
A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies
M. N. Gamaletsou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Epidemiology of candidaemia and invasive candidiasis. A changing face
Guillermo Quindos
REVISTA IBEROAMERICANA DE MICOLOGIA (2014)
Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme
M. C. Arendrup et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Maiken C. Arendrup et al.
DRUG RESISTANCE UPDATES (2013)
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
Marin Kollef et al.
CLINICAL INFECTIOUS DISEASES (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Optimizing a Candida Biofilm Microtiter Plate Model for Measurement of Antifungal Susceptibility by Tetrazolium Salt Assay
Jeniel E. Nett et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome
Hung-Wei Chi et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
Diagnosis of invasive candidiasis in the ICU
Philippe Eggimann et al.
ANNALS OF INTENSIVE CARE (2011)
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study
Marya D. Zilberberg et al.
BMC INFECTIOUS DISEASES (2010)
Epidemiology of invasive candidiasis
Maiken C. Arendrup
CURRENT OPINION IN CRITICAL CARE (2010)
Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections
Ingi Lee et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel et al.
CLINICAL INFECTIOUS DISEASES (2009)
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)
Olivier Leroy et al.
CRITICAL CARE MEDICINE (2009)
CANDIDA ALBICANS AND NON-ALBICANS BLOODSTREAM INFECTIONS IN ADULT AND PEDIATRIC PATIENTS COMPARISON OF MORTALITY AND COSTS
Cassandra Moran et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
Marya D. Zilberberg et al.
CRITICAL CARE (2009)
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections:: Differences in risk factors and outcome
George Dimopoulos et al.
ANESTHESIA AND ANALGESIA (2008)
The changing epidemiology of invasive Candidiasis - Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy
Ray Hachem et al.
CANCER (2008)
One year prospective survey of Candida bloodstream infections in Scotland
Frank C. Odds et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia
Mario Tumbarello et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
B Almirante et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Attributable mortality of nosocomial candidemia, revisited
O Gudlaugsson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins
DM Kuhn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
